English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Aims/Introduction  The present multicenter, cross‐sectional survey was initiated to evaluate self‐monitoring of blood glucose ( SMBG )‐associated mental distress among patients with diabetes.    Materials and Methods  The survey was carried out in patients with type 1 diabetes and type 2 diabetes using  SMBG  recruited from 42 medical institutions. Profiles of Mood States 2 and diabetes therapy‐related quality of life questionnaires were used to evaluate mood status and health‐related quality of life. Two original questionnaires were also developed to evaluate  SMBG  ‘importance,’ ‘painfulness’ and ‘confidence’ among patients, and to evaluate physician attitudes to  SMBG  use.    Results  Questionnaires from 517 type 1 diabetes and 1,648 type 2 diabetes patients showed that 46.0% of type 1 diabetes and 37.5% of type 2 diabetes patients reported ‘painfulness,’ and that these patients reporting ‘painfulness’ showed significantly higher Profiles of Mood States 2 scores, lower diabetes therapy‐related quality of life scores and higher glycated hemoglobin compared with those not reporting ‘painfulness,’ whereas the number of their daily  SMBG  tests were comparable. Patients reporting ‘painfulness’ also reported that  SMBG  use was significantly less important. Whether or not patients recognized the importance of  SMBG  use was well correlated with the frequency of physicians checking patient diaries.    Conclusions  Type 1 diabetes and type 2 diabetes patients reporting ‘painfulness’ in  SMBG  use had more mental distress, lower health‐related quality of life and higher glycated hemoglobin regardless of their number of daily  SMBG  tests. The importance of  SMBG  use was recognized less by patients experiencing pain, and the importance of  SMBG  use was recognized more in medical institutions in which physicians regularly checked  SMBG  diaries to provide meaningful feedback to patients in clinical settings.

journal of diabetes investigation

Mental distress and health‐related quality of life among type 1 and type 2 diabetes patients using self‐monitoring of blood glucose: A cross‐sectional questionnaire study in Japan